The Medical Device Industry's Focus on Cardio and Cardiovascular Needs

Friday, September 30, 2016 Heart Disease News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, September 30, 2016 /PRNewswire/ --

The medical devices market is very diverse, with devices that focus

on various medical needs and procedures. On area where innovation is expected is the cardiac medical devices market. A research report by Absolut Reports indicates what the issues are in the market today, and its potential growth. The cardiac medical
devices market in the US is estimated to grow at a CAGR of 1.82% during the period 2016-2020. . BioSig Technologies Inc. (OTCQB: BSGM), Medtronic PLC (NYSE: MDT), C R Bard Inc. (NYSE: BCR), Cardinal Health Inc. (NYSE: CAH), Edwards Lifesciences Corp. (NYSE: EW).

Two heart conditions atrial fibrillation (AF) and ventricular tachycardia (VT), characterized by irregular heartbeat, are quite common. This condition occurs when the heart is no longer able to properly function, a malfunction in the electrical impulses of the heart occurs. This could, in worth case scenarios lead to sudden cardiac arrest or heart failure. The Center for Disease Control has estimated that about 6 million people were diagnosed with AF in 2015, and it is most common in older populations, among people 60 years or above.

Medical device companies have always considered cardiology as one of the most important sectors. New innovations and developments have made heart rate measurements more accurate and analytical. Advancements are still being made in this sector and could lead to much bigger findings. BioSig Technologies Inc. (OTCQB: BSGM) for example is a development-stage medical device company which is focused on a technology platform to manage noises and artifacts from cardiac recordings during electrophysiology studies and ablation. The platform is the Precise Uninterrupted Real-time evaluation of Electrograms (PURE) electro-pneumatic (EP) System.

The PURE EP system is a novel platform designed to obtain and display important clinical data during electrophysiology procedures. BioSig Technologies Inc. ( BSGM) claims the system to be precise, uninterrupted, capable of real-time evaluations of Electrograms. The feature of the PURE EP System that are designed to improve upon today's devices used for similar procedures by detecting and displaying high fidelity cardiac signals, which the company claims are not detectable by other recording devices.  

The technology used in the PURE EP has been discussed in studies from Texas Cardiac Arrhythmia Institute, Mayo Clinic, Mount Sinai and UCLA with data presented at world-renowned conferences. The data positively indicates that the technology has the potential to shorten procedure time as well as eliminating, or the very least reducing the need for repeated procedures, which are frequent with devices used today. BioSig Technologies Inc. (BSGM) plans to apply via a 510(k) pathway with the Food and Drug Administration in the first half of 2017.

Large cap companies like Medtronic PLC (NYSE: MDT) is a medical technology and services company that manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The company has a cardiac and vascular segment includes products for cardiac rhythm and heart failure monitoring. The company's resynchronization therapy is a proven treatment for selected heart failure patients with a wide QRS. When used in combination with optimal medical therapy, cardiac resynchronization therapy improves symptoms and extends survival.

C R Bard Inc. (NYSE: BCR) is a designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The company has a cardiac monitoring division, which provides Temporary Pacing Electrode Catheters. The catheters designed to reduces the need for repositioning, saving physician time and minimizing patient discomfort.

Cardinal Health Inc. (NYSE: CAH) a healthcare services and products company. For evaluating cardiovascular disease, the company is known for Single-photon emission computed tomography (SPECT) which is a nuclear medicine tomographic imaging technique using gamma rays. Cardiac SPECT can identify areas of the heart which do not receive adequate blood flow during stress, called ischemia, as well as find areas of irreversibly damaged heart, or scar. It is considered to be a very important tool for detecting and evaluating cardiovascular disease.

Edwards Lifesciences Corp. (NYSE: EW) is focused on developing technologies that treat structural heart disease. The Company is known for their heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The company's cardio medical devices are hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. 

Subscribe Now! Watch us report from NYSE

For "The Latest Buzz in Financial News", SIGN UP & Visit:

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. has been compensated twelve thousand dollars for financial news pr services by a non-affiliated third party for biosig technologies inc. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on this site along with other financial news pr media services. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof.  The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print.  Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit:

For further information:

Media Contact: Danny A.,, +1-877-601-1879


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store